Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

Name: Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
License: Public Domain

Ludwig Institute for Cancer Research

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nsclc

metastatic non-small cell lung cancer, nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148772
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.